Revolution Medicines, Inc. RVMD
Set alert
191.31 USD +1.04 +0.55%
At close · Oct 30
191.25 -0.06 -0.03%
After hours · Oct 30, 7:33 PM ET
187.28 Day range 192.60
58.57 52-week range 221.15
- YTD
- +140.19%
- 1 year
- +224.97%
- Open
- 188.38
- Prev close
- 190.27
- Mkt cap
- 41.00B
- Vol
- 1.10M
- Avg vol
- 1.94M
- EPS
- -8.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 187.28
- High
- 192.60
- Forward P/E
- -33.19
- Beta
- 1.40
- Short ratio
- 5.55
- Inst. own
- 102.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 199.63
- 200-d avg
- 155.69
- 1y target
- 258.84
MAX chart
Events in this range
- Aug 6, 2025Earnings: -1.31; estimate -1.138; surprise -15.11%
- Nov 5, 2025Earnings: -1.61; estimate -1.42; surprise -13.38%
- Feb 25, 2026Earnings: -1.86; estimate -1.58; surprise -17.72%
- May 6, 2026Earnings: -2.29; estimate -1.84; surprise -24.46%
- Aug 5, 2026Earnings: -3.06; estimate -2.04; surprise -50%
- Oct 8, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 14, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 15, 2026Rating: Needham · Buy → Buy
- Oct 16, 2026Rating: William Blair · — → Outperform
- Oct 19, 2026Rating: Truist Securities · Buy → Buy
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
- Nov 4, 2026Earnings: —; estimate -2.35; surprise —%
Signals (111)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| RSI: Overbought | Oct 13, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| MACD: Buy Signal | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Dec 2, 2024 | 1 year ago |
| RSI: Overbought | Oct 28, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 7, 2024 | 2 years ago |
| RSI: Overbought | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 26, 2024 | 2 years ago |
| RSI: Overbought | Jul 15, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 1, 2024 | 2 years ago |
| RSI: Overbought | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Jan 22, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 25, 2023 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| SMA: Bearish | Oct 23, 2023 | 3 years ago |
| SMA: Bullish | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| RSI: Overbought | Aug 28, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 19, 2023 | 3 years ago |
| SMA: Bearish | Jun 12, 2023 | 3 years ago |
| MACD: Buy Signal | May 8, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Feb 13, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| SMA: Bearish | Jan 2, 2023 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| MACD: Buy Signal | Jun 13, 2022 | 4 years ago |
| MACD: Sell Signal | May 9, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bearish | Apr 4, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 21, 2022 | 4 years ago |
| MACD: Sell Signal | Dec 6, 2021 | 4 years ago |
| SMA: Bearish | Nov 15, 2021 | 4 years ago |
| SMA: Bearish | Nov 15, 2021 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
| SMA: Bullish | Oct 25, 2021 | 5 years ago |
| SMA: Bearish | Oct 4, 2021 | 5 years ago |
| MACD: Buy Signal | Sep 6, 2021 | 5 years ago |
| SMA: Bullish | Aug 30, 2021 | 5 years ago |
| SMA: Bearish | Jul 12, 2021 | 5 years ago |
| SMA: Bullish | Jun 14, 2021 | 5 years ago |
| SMA: Bearish | Apr 12, 2021 | 5 years ago |
| SMA: Bearish | Apr 5, 2021 | 5 years ago |
| SMA: Bullish | Mar 29, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| MACD: Sell Signal | Mar 22, 2021 | 5 years ago |
| MACD: Buy Signal | Feb 1, 2021 | 5 years ago |
| MACD: Sell Signal | Jan 25, 2021 | 5 years ago |
| SMA: Bullish | Jan 18, 2021 | 5 years ago |
| MACD: Buy Signal | Jan 18, 2021 | 5 years ago |
| SMA: Bearish | Jan 11, 2021 | 5 years ago |
| MACD: Sell Signal | Jan 11, 2021 | 5 years ago |
| SMA: Bullish | Nov 9, 2020 | 5 years ago |
| SMA: Bullish | Nov 2, 2020 | 6 years ago |
| SMA: Bearish | Oct 26, 2020 | 6 years ago |
| SMA: Bearish | Oct 26, 2020 | 6 years ago |
| RSI: Overbought | Oct 12, 2020 | 6 years ago |
| SMA: Bullish | Sep 14, 2020 | 6 years ago |
| SMA: Bullish | Sep 7, 2020 | 6 years ago |
| SMA: Bearish | Aug 31, 2020 | 6 years ago |
| SMA: Bullish | Aug 24, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| SMA: Bullish | Apr 20, 2020 | 6 years ago |
Key statistics
- Market cap
- 41.00B
- Enterprise value
- 38.03B
- Trailing P/E
- 0.00
- Forward P/E
- -33.19
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 15.73
- EPS (TTM)
- -8.87
- Beta
- 1.40
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -711.61M
- Total cash
- 3.94B
- Total debt
- 1.19B
- Return on equity
- -79.09%
- Shares outstanding
- 214.34M
- Short % of float
- 6.37%
- 50-day average
- 199.63
- 200-day average
- 155.69
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 258.84 +35.3% upside
Now 191.31
- Target (low)
- 179.00
- Target (mean)
- 258.84
- Target (high)
- 320.00
Ratings (0m) 25 24 buy · 1 hold · 0 sell
- Strong buy5
- Buy19
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate -2.38.
Financials — quick view
RVMD Revenue — quarterly 0
RVMD Net income — quarterly -644.37M
RVMD EPS — quarterly -3.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | -2.35 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | -2.04 | -3.06 | -1.02 | -50.00% |
| May 6, 2026 | Mar 31, 2026 | -1.84 | -2.29 | -0.45 | -24.46% |
| Feb 25, 2026 | Dec 31, 2025 | -1.58 | -1.86 | -0.28 | -17.72% |
| Nov 5, 2025 | Sep 30, 2025 | -1.42 | -1.61 | -0.19 | -13.38% |
| Aug 6, 2025 | Jun 30, 2025 | -1.14 | -1.31 | -0.17 | -15.11% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | reit | Buy | Buy |
| Oct 19, 2026 | Truist Securities | main | Buy | Buy |
| Oct 16, 2026 | William Blair | init | — | Outperform |
| Oct 15, 2026 | Needham | reit | Buy | Buy |
| Oct 14, 2026 | RBC Capital | main | Outperform | Outperform |
| Oct 8, 2026 | RBC Capital | main | Outperform | Outperform |
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- revmed.com
News
- Earnings Volatility Watch: 10 Stocks Are Set to Swing More Than 10% This Week
- Could Revolution Medicines Be a Millionaire-Maker Stock?
- Jim Cramer: This Tech Stock ‘Sells At A Low Multiple’
- Revolution Medicines, Inc. $RVMD Holdings Cut by Citizens Financial Group Inc. RI
- Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run?
- Revolution Medicines to Participate in November 2026 Investor Conferences
- Why Is Tango Therapeutics Stock Trading Lower After Cancer Drug Data?
- Here’s How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years
- Revolution Medicines Presents Exploratory Subgroup Analyses From Phase 3 RASolute 302 Trial, As Late-Breaking Abstract At ESMO Congress 2026
- Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026
Your note
Sign in to keep a note on RVMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDERS JACK LEE | Chief Financial Officer | Sale | Jun 23, 2026 | 123,269 |
| BORISY ALEXIS | Director | Stock Award(Grant) | Jun 17, 2026 | 2,340,080 |
| GOLDSMITH MARK A | Chief Executive Officer | Sale | Aug 20, 2026 | 0 |
| HORN MARGARET A | Chief Operating Officer | Sale | Jun 16, 2026 | 154,647 |
| HORNING SANDRA | Director | Stock Award(Grant) | Jun 17, 2026 | 97,765 |
| KELSEY STEPHEN MICHAEL | Officer | Sale | Sep 10, 2026 | 291,876 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.39% | 13,695,790 | 2.62B | Jun 29, 2026 |
| Farallon Capital Management LLC | 6.32% | 13,550,796 | 2.59B | Jun 29, 2026 |
| FMR, LLC | 5.69% | 12,200,422 | 2.33B | Jun 29, 2026 |
| Baker Bros. Advisors, LP | 5.34% | 11,443,357 | 2.19B | Jun 29, 2026 |
| Jupiter Topco LLC | 5.01% | 10,736,145 | 2.05B | Jun 29, 2026 |
| Darwin Global Management, Ltd. | 4.96% | 10,629,822 | 2.03B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.99% | 6,412,413 | 1.23B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.16% | 4,631,150 | 885.99M | Jun 29, 2026 |
| Growth Fund of America | 1.38% | 2,964,768 | 567.19M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.25% | 2,670,853 | 510.96M | Jun 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.15% | 2,472,885 | 473.09M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.07% | 2,291,511 | 438.39M | Jun 29, 2026 |